---
title: "This Biotech Leader Ran Up As Much As 18% — And Then Lost It All"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286798319.md"
description: "Shares of Design Therapeutics experienced a significant surge on Monday following positive results in the treatment of Friedreich's ataxia, reaching an increase of up to 18%. However, the biotech company quickly saw these gains disappear. This fluctuation underscores the volatile nature of the market, illustrating the rapid shifts that can occur in stock value. Investors Business Daily covered this story, highlighting the rollercoaster ride that Design Therapeutics' shares took on this particular day."
datetime: "2026-05-18T16:02:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286798319.md)
  - [en](https://longbridge.com/en/news/286798319.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286798319.md)
---

# This Biotech Leader Ran Up As Much As 18% — And Then Lost It All

Shares of Design Therapeutics experienced a significant surge on Monday following positive results in the treatment of Friedreich's ataxia, reaching an increase of up to 18%. However, the biotech company quickly saw these gains disappear. This fluctuation underscores the volatile nature of the market, illustrating the rapid shifts that can occur in stock value. Investors Business Daily covered this story, highlighting the rollercoaster ride that Design Therapeutics' shares took on this particular day.

### Related Stocks

- [DSGN.US](https://longbridge.com/en/quote/DSGN.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Dyadic International Q1 net loss narrows](https://longbridge.com/en/news/286311192.md)
- [Corvus Pharmaceuticals presents Phase 1 soquelitinib data showing durable remissions, favorable safety](https://longbridge.com/en/news/286404245.md)
- [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)